Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma of Lung × palbociclib × Clear all

Sponsor

Conditions

Breast Neoplasms 49 Squamous Cell Carcinoma of Head and Neck 4 Neoplasm Metastasis 4 Sarcoma 3 Carcinoma, Non-Small-Cell Lung 3 Astrocytoma 3 Sarcoma, Ewing 2 Oligodendroglioma 2 Medulloblastoma 2 Lymphoma 2 Glioma 2 Glioblastoma 2 Colonic Neoplasms 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Neuroepithelial 1 Neoplasms 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1

Interventions

Carboplatin 22 Bevacizumab 17 Paclitaxel 16 Pemetrexed 14 Radiotherapy 11 Erlotinib Hydrochloride 11 Docetaxel 7 Gemcitabine 5 Cetuximab 5 ceritinib 4 Taxes 4 Cisplatin 4 pembrolizumab 3 Surgical Procedures, Operative 3 Radiosurgery 3 Metformin 3 Gefitinib 3 Cyclophosphamide 3 pegfilgrastim 2 capmatinib 2 Thalidomide 2 Sorafenib 2 Radiotherapy, Conformal 2 Nivolumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Albumin-Bound Paclitaxel 2 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 2 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡